This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com
Dallas, TX (PRWEB) November 27, 2012
The latest financial report from German drugmaker Bayer offers patients some clarification on which cases qualify for a Yaz settlement and how much the claims may be worth.
According to the Business Development and Legal Notes section of the Bayer Interim Financial Statement on September 30, 2012, the company is only settling claims involving blood clot injuries, such as deep vein thrombosis and pulmonary embolism,
Also, Bayer confirmed they have resolved nearly 3,500 injury claims for a total cost of nearly $750 million, or an average of approximately $214,000 per case.
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.
The news comes as the American College of Obstetricians and Gynecologists last month renewed warnings that birth control pills containing drospirenone such as Yaz and Yasmin may have a higher risk of causing blood clots, according to the Chicago Tribune on October 24, 2012.
In October of 2011, the FDA released a study entitled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" which found that drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.
Due to the number of claims, a federal Multi-District Litigation court was established in Illinois to handle Yaz lawsuits filed by those injured. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).
The news of additional Yaz lawsuit settlements is positive for those injured who have yet to file a claim. However, time is limited and only certain cases may qualify.
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism and believes it may be due to taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.
The Drug Risk Resource Center cautions that victims should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.
For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebyaz-lawsuit/defective-drugs/prweb10171444.htm